Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 22, Issue 4, 2007, Pages 223-230

  Gotuzzo, Eduardo ^a   Moody, Joel ^b   Verdonck, Kristien ^a,c   Cabada, Miguel M ^a   González, Elsa ^a   Van Dooren, Sonia ^d   Vandamme, Anne Mieke ^d   Terashima, Angélica ^a   Vermund, Sten H ^e  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast feeding; Disease transmission, vertical; HTLV 1 infections transmission; HTLV 1 associated myelopathy; Human T lymphotropic virus 1; Offspring; Paraparesis, tropical spastic; Peru; Strongyloidiasis

Indexed keywords

BREASTFEEDING; DISEASE TRANSMISSION; INFECTIOUS DISEASE; LOGISTICS; PARASITIC DISEASE; REGRESSION ANALYSIS; WOMENS HEALTH;

LIMA [PERU]; PERU; SOUTH AMERICA;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 37649025938     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892007000900001     Document Type: Article

References (36)

1. Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415-9.
2. Ando Y, Matsumoto Y, Nakano S, Saito K, Kakimoto K, Tanigawa T, et al. Long-term follow up study of vertical HTLV-I infection in children breast-fed by seropositive mothers. J Infect. 2003;46(3):177-9.
3. Fujino T, Nagata Y. HTLV-I transmission from mother to child. J Reprod Immunol. 2000;47(2):197-206.
4. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, et al. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005;191(9):1490-7.
5. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984;46(5): 245-53.
6. Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, et al. Patterns of HTV-I and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis. 1990;162(2):347-52.
7. Blattner WA. Epidemiology of HTLV-I and associated diseases. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press; 1990.
8. Bittencourt AL, Sabino EC, Costa MC, Pedroso C, Moreira L. No evidence of vertical transmission of HTLV-I in bottle-fed children. Rev Inst Med Trop Sao Paulo. 2002;44(2):63-5.
9. Wiktor SZ, Pate EJ, Rosenberg PS, Barnett M, Palmer P, Medeiros D, et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breastfeeding. J Hum Virol. 1997;1(1):37-44.
10. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepere JF, Buigues RP, et al. Mother-to-child transmission of human T-cell-leukemia/ lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer. 1999;82(6):832-6.
11. Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B, et al. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis. 2004;190(7):1275-8.
12. Biggar RJ, Ng J, Kim N, Hisada M, Li HC, Cranston B, et al. Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I. J Infect Dis 2006;193(2):277-82.
13. Sanchez-Palacios C, Gotuzzo E, Vandamme AM, Maldonado Y. Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-1) infection among ethnically and geographically diverse Peruvian women. Int J Infect Dis. 2003;7(2):132-7.
14. Alarcon JO, Friedman HB, Montano SM, Zunt JR, Holmes KK, Quinnan GV Jr. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in Peru. J Acquir Immune Defic Syndr. 2006;42(5):604-9.
15. Fuentes J, Roca O. Peru's experience with a national blood banking program. Rev Panam Salud Publica. 2003;13(2-3):165-71.
16. Gotuzzo E. Risk of transfusion-transmitted human T-cell lymphotropic virus-type I in Latin America. Int J Infect Dis. 2000;4(2): 59-61.
17. Gotuzzo E, Cabrera J, Deza J, Verdonck K, Vandamme AM, Cairampoma R, et al. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1associated tropical spastic paraparesis. Clin Infect Dis. 2004;39(7):939-44.
18. Araujo A, Hall WW. Human T-lymphotropic virus type II and neurological disease. Ann Neurol. 2004;56(1):10-9.
19. Zunt JR, La Rosa AM, Peinado J, Lama JR, Suarez L, Pun M, et al. Risk factors for HTLV-II infection in Peruvian men who have sex with men. Am J Trop Med Hyg 2006;74(5): 922-5.
20. Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-1 infection. Int J Infect Dis. 2002;6(1): 28-30.
21. Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg. 1999;60(1): 146-9.
22. Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, et al. Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg. 2006;74(2):246-9.
23. World Health Organization (WHO). Report of the scientific group on HTLV-I infections and associated diseases (Kagoshima, Japan, 10-15 December 1988). Manila: WHO; 1989. Pp 17-8.
24. Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retroviral. 1997;14(3):263-71.
25. Rice S, Coombs D, Fish L, Leeper J. Breast-feeding and contraception in Peru. J Health Popul Nutr. 2002;20(1):51-8.
26. Hisada M, Maloney EM, Sawada T, Miley WJ, Palmer P, Hanchard B, et al. Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica. Clin Infect Dis. 2002;34(12):1551-7.
27. Arango C, Rugeles MT, Concha M, Borrero II, Lai H, Lai S, et al. Risk factors for HTLV-I mother-to-child transmission: influence of genetic markers. Braz J Infect Dis. 1998;2(3): 135-42.
28. Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruyama I, Osame M, Sonoda, S. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol. 1993;42(2): 147-54.
29. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4(6):586-93.
30. Montanheiro PA, Oliveira AC, Posada-Vergara MP, Milagres AC, Tauil C, Marchiori PE, et al. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res. 2005; 38(11): 1643-1647.
31. Gabet AS, Mortreux F, Talarmin A, Plumelle Y, Leclercq I, Leroy A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000;19(43): 4954-60.
32. Plancoulaine S, Gessain A, Joubert M, Tortevoye P, Jeanne I, Taralmin A, et al. Detection of a major gene predisposing to human T lymphotropic virus type I infection in children among an endemic population of African origin. J Infect Dis. 2000;182(2): 405-12.
33. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000; 165: 7278-84.
34. Rouet F, Meertens L, Courouble G, Herrmann-Storck C, Pabingui R, Chancerel B, et al. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean. J Clin Microbiol. 2001;39(4):1247-53.
35. Proietti FA, Carneiro-Proietti AB, CatalanSoares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39):6058-68.
36. Kashiwagi K, Furusyo N, Nakashima H, Kubo N, Kinukawa N, Hayashi J. A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan. Am J Trop Med Hyg. 2004:70(2): 158-63.